J. NRSA Training Core

摘要 对于ITM 3.0，我们要求继续资助TL 1博士后项目，该项目在过去五年中为18名博士后研究员提供了临床研究和生物医学信息学方面的培训。目前的博士后TL 1计划于2017年开始，取代了早期的博士前课程;它由芝加哥大学和拉什大学的合作项目组成，其目标是通过整合临床研究和生物医学信息学培训，为博士后学员作为独立和合作的翻译研究人员做好准备。对于ITM 3.0，我们将建立在现有的程序结构和新的培训机会，在临床研究，生物医学信息学和公共卫生提供跨学科的博士后研究培训，为研究员提供指导框架和技能，以帮助通过转化研究促进健康走向健康公平。这个程序的新迭代，称为TL 1 临床研究，生物医学信息学和健康公平的博士后培训计划，将纳入U芝加哥，拉什和洛约拉大学芝加哥的研究培训机会，提供临床研究，信息学和公共卫生的教学培训。此外，该计划将提供教师指导的研究 机会和同伴学习的机会。像TL 1这样的博士后培训项目对于建立一个强大，持久的管道，以培养下一代临床和转化研究领导者至关重要，他们优先考虑将健康促进健康公平作为他们研究的目标。迄今为止，TL 1博士后学员中有11%的人自认为是代表性不足的少数群体的成员。在ITM 3.0中，我们将加倍努力吸引那些自认为代表性不足的少数民族的学员。学员将 在研究生院或医学院完成博士前培训后，并在教师任命之前，从事这一博士后计划。这种博士后培训的目的是为早期职业调查人员提供受保护的时间和学费支持，以追求高级课程和从事指导研究， 他们可以成功地竞争教师职位，职业发展奖和独立的研究资金。

ABSTRACT For ITM 3.0, we request continued funding for the TL1 Postdoctoral Program, which over the past five years has provided training in clinical research and biomedical informatics to 18 postdoctoral fellows. This current postdoctoral TL1 program was begun in 2017, replacing an earlier predoctoral program; it is comprised of collaborating programs at UChicago and Rush, and its goal has been to prepare postdoctoral trainees for careers as independent and collaborative translational researchers through the integration of clinical research and biomedical informatics training. For ITM 3.0, we will build on the existing program structure and new training opportunities in clinical research, biomedical informatics, and public health to offer interdisciplinary postdoctoral research training that provides fellows with a guiding framework and skillset to help advance health toward health equity through translational research. The new iteration of this program, called the TL1 Postdoctoral Training Program in Clinical Research, Biomedical Informatics, and Health Equity, will incorporate research training opportunities at UChicago, Rush, and Loyola University Chicago to offer didactic training in clinical research, informatics, and public health. In addition, the program will provide faculty-mentored research opportunities and peer learning opportunities. Postdoctoral training programs such as the TL1 are critical to building a strong, enduring pipeline for developing the next generation of leaders in clinical and translational research who prioritize advancing health toward health equity as a goal of their research. To date, 11% of TL1 postdoctoral trainees have self-identified as a member of an underrepresented minority group. In ITM 3.0, we will redouble our effort to attract trainees who self-identify as under-represented minorities. Trainees will engage in this postdoctoral program after completing predoctoral training in graduate or medical school, and before a faculty appointment. The purpose of this postdoctoral training is to provide protected time and tuition support for early-career investigators to pursue advanced coursework and engage in mentored research, so they can successfully compete for faculty jobs, career development awards, and independent research funding.